Cargando…
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
BACKGROUND: Uveal melanoma is a rare form of cancer with high mortality. The incidence of metastases is attributed to early seeding of micrometastases from the eye to distant organs, primarily the liver. Once these seeded clusters of dormant tumor cells grow into larger radiologically detectable mac...
Autores principales: | Hagström, Anna, Kal Omar, Ruba, Williams, Pete A., Stålhammar, Gustav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006630/ https://www.ncbi.nlm.nih.gov/pubmed/35413810 http://dx.doi.org/10.1186/s12885-022-09464-w |
Ejemplares similares
-
Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
por: Kal Omar, Ruba, et al.
Publicado: (2023) -
A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022) -
Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020) -
The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989
por: Stålhammar, Gustav, et al.
Publicado: (2022) -
Sex‐based differences in early and late uveal melanoma‐related mortality
por: Stålhammar, Gustav
Publicado: (2022)